Section Editors

  • Michael Aschner, Vanderbilt University
  • Phil Biggin, University of Oxford
  • Lucio Guido Costa, University of Washington
  • David H Farb, Boston University School of Medicine
  • Giorgio Palu, University of Padova

Executive Editor

  • Christopher Morrey, BioMed Central

Articles

There has been an error retrieving the data. Please try again.
  • Image attributed to: Flickr by Army Medicine

    Transformation for translational toxicology

    The integration of exposure assessment, basic toxicology and models to investigate effective interventions that mitigate or reverse adverse effects of environmental exposures may represent an effective portfolio to improve health by minimizing exposure and producing specific therapeutics.

    BMC Pharmacology and Toxicology 2013, 14:51
  • Image attributed to: Wikimedia Commons by MarinaVladivostok

    Nebivolol-stimulated nitric oxide and peroxynitrite release

    The ability of nebivolol to stimulate nitric oxide release appears to be independent of its selective beta1-adrenoceptor blockade properties and dependent on stimulation of beta3-adrenoceptors and ATP-mediated stimulation of P2Y-purinergic receptors in human endothelial cells.

    BMC Pharmacology and Toxicology 2013, 14:48
  • Image attributed to: Flickr by Dominic Alves

    Breaking down the barrier of translational sciences

    Section Editor David Farb provides his insights on recent developments in the field of pharmacology and discusses his future aspirations for BMC Pharmacology and Toxicology.

    BMC Pharmacology and Toxicology 2013, 14:42
  • Image attributed to: BMC Pharmacology and Toxicology 2013, 14:37

    A novel transcriptional sensor for GABA receptor activity

    Polycomblike protein PHF1b stimulates GABRB1 promoter activity in primary cultured neurons and chronic GABA exposure regulates PHF1 binding to endogenous Gabrb1 indicating its role as a molecular transducer of GABA-mediated neurotransmission.

    BMC Pharmacology and Toxicology 2013, 14:37
  • Image attributed to: BMC Pharmacology and Toxicology 2013, 14:36

    Identification of a promising new CK2 inhibitor

    Cell-free, in vitro and molecular docking studies indicate that the phytoestrogen coumestrol is a novel ATP competitive and cell permeable Casein kinase 2 (CK2) inhibitor with a submicromolar IC50.

    BMC Pharmacology and Toxicology 2013, 14:36
  • Image attributed to: BMC Pharmacology and Toxicology 2013, 14:31

    Modeling protein-protein interfaces involving an alpha helix

    Computational analysis of proteins that interact with alpha-helical peptides suggests no sequence requirements for binding and highlights the presence of hydrophobic regions at the protein surface and non-uniform hydrophobicity across binding pockets.

    BMC Pharmacology and Toxicology 2013, 14:31

Latest review

Wikimedia Commons by DBCLS

Review Highly Accessed

Role of astrocytes in manganese mediated neurotoxicity

Marta Sidoryk-Wegrzynowicz and Michael Aschner

BMC Pharmacology and Toxicology 2013, 14:23 (18 April 2013)

RSS

Comments

View more comments

Scope

BMC Pharmacology and Toxicology is an open access, peer-reviewed journal that considers articles on all aspects of chemically defined therapeutic and toxic agents. The journal welcomes submissions from all fields of experimental and clinical pharmacology including clinical trials.

It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.

Section Editor's profile

David H Farb

David H Farb is Professor and Chair of the Department of Pharmacology and Experimental Therapeutics at Boston University School of Medicine. He is Principal Investigator and Director of the Laboratory of Molecular Neurobiology and Director of the university-wide NIGMS training program in Biomolecular Pharmacology. A renowned neuropharmacologist, his research integrates existing electrophysiological, behavioral, pharmacological, and molecular genetic technologies in a novel systems-level platform to establish a molecular dissection of spatial memory. Dr Farb is Section Editor for 'Basic pharmacology' and you can read more about the key issues in this field and his aspirations for the journal in his recent interview here.

"Pharmacology is a powerful interdisciplinary science providing an essential link between hypotheses developed from molecular, systems, and clinical models with the ultimate goal of improving human health. Our journal publishes timely research describing advances in a broad range of disciplines that combine novel approaches within a framework of rigorous scientific research."

Join the Editorial Board!

Are you interested in becoming an Editorial Board member for BMC Pharmacology and Toxicology and helping to maintain the editorial standards and ethos of this growing journal? To volunteer as an Associate Editor, please simply contact us at bmcpharmacoltoxicol@biomedcentral.com, enclosing a summary of your research interests and relevant expertise. We look forward to hearing from you.

BMC Pharmacology

BMC Pharmacology and Toxicology assimilated the Editorial boards and history of BMC Pharmacology and BMC Clinical Pharmacology on fusion of the journals in 2012. The full archive of BMC Pharmacology is available from its own archive website, and the objectives and aspirations of the merged journal are explained in the editorial that accompanied the fusion. The full archive of BMC Clinical Pharmacology is available here.